Metis Global Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.29M | Sell |
14,118
-1,581
| -10% | -$704K | 0.16% | 108 |
|
|
2025
Q1 | $7.61M | Buy |
15,699
+1,814
| +13% | +$879K | 0.21% | 84 |
|
|
2024
Q4 | $5.59M | Buy |
13,885
+430
| +3% | +$173K | 0.17% | 101 |
|
|
2024
Q3 | $6.26M | Buy |
13,455
+1,007
| +8% | +$468K | 0.19% | 86 |
|
|
2024
Q2 | $5.83M | Sell |
12,448
-63
| -0.5% | -$29.5K | 0.2% | 79 |
|
|
2024
Q1 | $5.23M | Buy |
12,511
+72
| +0.6% | +$30.1K | 0.19% | 87 |
|
|
2023
Q4 | $5.06M | Sell |
12,439
-475
| -4% | -$193K | 0.2% | 87 |
|
|
2023
Q3 | $4.49M | Buy |
12,914
+1,411
| +12% | +$491K | 0.22% | 94 |
|
|
2023
Q2 | $4.05M | Sell |
11,503
-12
| -0.1% | -$4.22K | 0.22% | 93 |
|
|
2023
Q1 | $3.63M | Buy |
11,515
+2,311
| +25% | +$728K | 0.23% | 92 |
|
|
2022
Q4 | $2.66M | Buy |
9,204
+3,078
| +50% | +$889K | 0.24% | 101 |
|
|
2022
Q3 | $1.77M | Buy |
6,126
+351
| +6% | +$102K | 0.29% | 77 |
|
|
2022
Q2 | $1.63M | Buy |
5,775
+1,757
| +44% | +$495K | 0.26% | 87 |
|
|
2022
Q1 | $1.05M | Buy |
4,018
+1,756
| +78% | +$458K | 0.13% | 151 |
|
|
2021
Q4 | $497K | Buy |
+2,262
| New | +$497K | 0.14% | 164 |
|